Download Files:
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate
$125 – $840
Products Details
Product Description
– Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate has the potential for the research of type 1 diabetes mellitus[1].
Web ID
– HY-138688
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C19H15NO4
References
– [1]Wang X, et al. 12(S)-hydroxyeicosatetraenoic acid impairs vascular endothelial permeability by altering adherens junction phosphorylation levels and affecting the binding and dissociation of its components in high glucose-induced vascular injury. J Diabetes Investig. 2019;10(3):639-649.
CAS Number
– 132465-11-3
Molecular Weight
– 321.33
Compound Purity
– 98.71
SMILES
– O=C(OC/C=C/C1=CC=CC=C1)/C(C#N)=C/C2=CC=C(O)C(O)=C2
Clinical Information
– Phase 3
Research Area
– Metabolic Disease; Cancer
Solubility
– DMSO : 50 mg/mL (ultrasonic)
Target
– Lipoxygenase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
